Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
08/2006
08/24/2006WO2006031560A3 Process for concentration of antibodies and therapeutic products thereof
08/24/2006WO2006029078A3 Targeting transducible molecules to specific cell types
08/24/2006WO2004033641A3 Gene expression profiling of bladder cancer
08/24/2006WO2003087300A3 Secreted proteins
08/24/2006US20060189797 Magnetic polymer particles
08/24/2006US20060189796 Separating agent for enantiomeric isomers
08/24/2006US20060189790 Removal of lipopolysaccharides from protein-lipopolysaccharide complexes by non flammable solvents.
08/24/2006US20060188970 High pressure refolding of protein aggregates and inclusion bodies
08/24/2006US20060188916 Joining spacer to biopolymers; generate spacer, join to bioplymer, recover biopolymer; conjugation that can be carried out entirely in the solid phase, with minimal disruption to automated synthetic protocols
08/24/2006US20060188876 Binding a target substance
08/24/2006US20060188515 Polypeptides for inducing a protective immune response against staphylococcus aureus
08/24/2006US20060188513 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians
08/24/2006US20060187526 Charged particle, microcapsule, electrophoretic device, electro-optical device, and method of forming a microcapsule
08/24/2006CA2594666A1 Use of activated polymers for separation of protein and polypeptide multimers
08/23/2006EP1693384A2 Functional immunoglobulins against human serum albumin, fragments thereof, library thereof and methods of production thereof
08/23/2006EP1692156A2 Self-assembling split-fluorescent protein systems
08/23/2006EP1691764A2 Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a
08/23/2006EP1648923A4 Spatially-defined macrocycles incorporating peptide bond surrogates
08/23/2006EP1648922A4 Spatially-defined macrocyclic compounds useful for drug discovery
08/23/2006EP1507794B1 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
08/23/2006EP1292612B1 Glycopeptide phosphonate derivatives
08/23/2006EP1240337B1 Methods and compositions for prolonging elimination half-times of bioactive compounds
08/23/2006EP1007541B1 Randomly generated glycopeptide combinatorial libraries
08/23/2006EP0952980B1 Acyl transfer with stabilised transition complex using catalyst with catalytic imidazole (e.g. histidine) function
08/23/2006CN1821274A Method for removing protein of Brazil mushroom crude polysaccharide
08/23/2006CN1821267A Method for refining sik fibroin
08/23/2006CN1821266A Process for extracting bread worm protein
08/23/2006CN1821265A Method for extracting ancient human remains matter DNA
08/23/2006CN1821264A Method and device for extracting protein from waste water of potato starch production
08/23/2006CN1821209A Process for coproducing fatty acid ester, glycerin and plant crude protein
08/23/2006CN1271203C Trehalose-releasing enzyme and process for producing saccharides using the same enzymes
08/23/2006CN1271085C Rapid separating purification of R-phycoerythrin
08/23/2006CN1271084C Bacillus subtilis antibacterial peptide separating and purifying method
08/22/2006US7094943 Solution phase biopolymer synthesis
08/22/2006US7094880 Decorin proteoglycan inhibitor of fibrinogen blood clotting
08/22/2006US7094879 Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof
08/22/2006US7094876 Human cDNAs and proteins and uses thereof
08/22/2006US7094872 Activated polyethylene glycol esters
08/22/2006US7094871 Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution
08/22/2006US7094759 peptide having a specific amino acid sequence suppresses initial adhesion of intraoral bacteria to teeth and periodontal tissue and prevents formation of a biofilm in an oral cavity.
08/22/2006US7094609 Spatially addressable combinatorial chemical arrays in encoded optical disk format
08/22/2006US7094568 Generation of preferential proteins; provide nucleotide sequences, amplify, incubate nucleotide sequences with nuclease, clone sequences into expression vector, express coded proteins, recover proteins
08/22/2006US7094565 polynucleotides that code polypeptides having oxidoreductase or alcohol dehydrogenase activity, used for drug screening, diagnosis and prophylaxis of brain, gastrointerstinal or urogenital disorders
08/22/2006US7094548 Polypeptide for use in purifying and separation of target peptides
08/22/2006US7094532 Use of polynucleotides and peptides in analysis of human norepinephrine (NE) transporter variants; diagnostic and therapeutic applications; human NE transporter polymorphism
08/22/2006US7094407 Self cell-penetrating Tat peptide having a self penetrating signal is bound to a human Type-I collagen C-terminal derived peptide
08/17/2006WO2006085984A2 Immune cell biosensors and methods of using same
08/17/2006WO2006085806A1 Liquid chromatography column
08/17/2006WO2006050155A3 Cancer therapeutic compositions
08/17/2006WO2005112977A3 Compositions for treatment with glucagon-like peptide, and methods of making and using the same
08/17/2006WO2005092013A3 Separations platform based upon electroosmosis-driven planar chromatography
08/17/2006WO2005081959A3 Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefor
08/17/2006WO2005065239A8 Novel recombinant proteins with n-terminal free thiol
08/17/2006WO2005016116A3 Hemostatic devices containing a protein precipitate
08/17/2006WO2003066831A3 Angiogenesis genes
08/17/2006US20060183918 Beta 2-adrenergic receptor agonists
08/17/2006US20060183889 Alkyl phosphine detergent products and extraction processes
08/17/2006US20060183691 Anti-hypertensive molecules and process for preparation thereof
08/17/2006US20060183669 separating two forms of a polypeptide having a single amino acid racemization by eluting the two forms of the polypeptide from an ion exchange chromatography resin under conditions where the salt concentration is increased at a pH that is no more than 1 pH unit from a pKa of X
08/17/2006US20060183191 Synthetic approach to designed chemical structures
08/17/2006US20060183156 PrPSc-selective peptides
08/17/2006US20060182739 By ion exchange chromatography and involves changing the conductivity and/or pH of buffers in order to resolve the polypeptide of interest
08/17/2006DE102005005828A1 Makroporöses Kunststoffperlenmaterial Macroporous plastics bead material
08/17/2006CA2614507A1 Immune cell biosensors and methods of using same
08/17/2006CA2597044A1 5-fluoro-uracil immunoassay
08/16/2006EP1689863A1 Template fixed beta-hairpin loop mimetics and their use in phage display
08/16/2006EP1689850A2 Inhibition of retroviral replication through modulation of the host cell ubiquitylation
08/16/2006EP1689778A1 Rgd targeting moiety its porduction and use
08/16/2006EP1689769A1 Separation methods
08/16/2006EP1689508A1 Reactor for solid phase synthesis
08/16/2006EP1627081A4 Use of jag2 expression in diagnosis of plasma cell disorders
08/16/2006EP1581797A4 Methods for the detection, analysis and isolation of nascent proteins
08/16/2006EP1578777A4 Iap binding compounds
08/16/2006EP1543155A4 Methods and compositions for analyzing polymers using chimeric tags
08/16/2006EP1019075B9 Beta 2-adrenergic receptor agonists
08/16/2006CN1820024A Novel poly(ethylene glycol) modified compounds and uses thereof
08/16/2006CN1820018A Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands
08/16/2006CN1818069A Preparation of genetic recombinant fusion protein PFK-K5
08/16/2006CN1817904A Gerobriecin pancrease glucagon peptidel (SGLP-1), its preparation and use
08/16/2006CN1817903A Phosphoinositolglycan (PIG)-binding protein from adipocytes
08/16/2006CN1817902A Recombinant scorpion toxin, its soluble expression and purification
08/16/2006CN1817899A Polypeptide of ascidicea and preparation thereof
08/16/2006CN1817444A Production of silica-gel carried dye affinity substrate and use thereof
08/16/2006CN1269959C Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
08/16/2006CN1269955C Manufacture of hemoglobin-based oxygen carrier
08/16/2006CN1269776C Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
08/15/2006US7092825 Creating a computer database which includes a plurality of entries; creating a query corresponding to a description of a location and orientation in 3D space of each side chain of two or more amino acid residues of a sample protein; searching database with query ; identifying the amino acid residue(s)
08/15/2006US7091331 Nucleic acid molecules and polypeptides encoding baboon TAFI
08/15/2006US7091319 IL-3 variant hematopoiesis fusion protein
08/15/2006US7091317 Enhanced green fluorescent protein for use as diagnostic tool in monitoring gene expression, function and localization
08/15/2006US7091316 Protein induced by homogeneous blood transfusion and DNA encoding the same
08/15/2006US7091315 heterologous polypeptide is the Fc domain of immunoglobulins, used to stimulate biosynthesis of interferons, or for diagnosis or prophylaxis of diseases; immunostimulants
08/15/2006US7091314 Intermediates and methods for making heptapeptide oxytocin analogues
08/15/2006US7091313 Coupling a solid support derived from polystyrene with N-protected derivative of amino acid, removing N-protecting group, coupling the product thus obtained with N-protected derivative of amino acid; removing protecting group, repeating the procedure, coupling, cyclization
08/15/2006US7091022 Mitogen activated kinase
08/15/2006US7091021 Inactive variants of the human telomerase catalytic subunit
08/15/2006US7091019 The use of these proteins enables the transformation of a hop by gene manipulations as well as enables the in vitro synthesis of the secondary metabolites of a hop.
08/15/2006US7090989 Recombinant human SM-11044-binding receptor proteins exhibiting ligand-binding activities, and their uses
08/15/2006US7090857 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid
08/15/2006US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder